EPHA10 and neoplasm: Although the effects of these CAR T-cells remain to be tested in immunocompetent models, anti-EphA10 antibodies increased the infiltration and activity of cytotoxic T-cells in a syngeneic 4T1 tumor model, suggesting that blocking EphA10 on TAMs/MDSCs restores T-cell activity [171].